Literature DB >> 4675028

Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture.

A H Gerulath, T L Loo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4675028     DOI： 10.1016/0006-2952(72)90384-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines.

Authors:  T D Quinn; H C Polk; M J Edwards
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

2.  Application of a microsomal drug activation system in a human tumor cloning assay.

Authors:  H R Metelmann; D D Von Hoff
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

3.  Clinical pharmacokinetics of high-dose DTIC.

Authors:  J M Buesa; E Urréchaga
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents.

Authors:  R Bianchi; L Citti; R Beghetti; L Romani; M D'Incalci; P Puccetti; M C Fioretti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  DTIC and CPZ cytotoxicities on established human melanocyte cell lines.

Authors:  C Aubert; F Rouge
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

7.  Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors:  H Breithaupt; A Dammann; K Aigner
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.

Authors:  P G Larsson; F Haffner; G O Brłnstad; T Christoffersen
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.